Current Reversible Agents for Oral Anticoagulants
The new anticoagulants also target thrombin or the Xa factor, which include rivaroxaban as well as apixaban. These anticoagulants are widely used within the US, and are approved by NOACs. They are advanced clinically and serve purposes as found in
Read More →